You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 3, March 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Routine Neuroimaging in Retinoblastoma for the Detection of Intracranial Tumors

Arch Ophthalmol. 2001;119:450-452.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The occurrence of a midline intracranial primitive neuroectodermal tumor (PNET) with bilateral retinoblastoma has been called "trilateral retinoblastoma."1 This rare complication of heritable retinoblastoma is associated with an extremely poor prognosis, accounting for up to 50% of tumor-associated mortality among patients with retinoblastoma.2

Primitive neuroectodermal tumors usually occur 2 to 4 years after diagnosis of bilateral retinoblastoma. However, PNETs have been diagnosed in patients with unilateral retinoblastoma 6 months before diagnosis of bilateral retinoblastoma and in 2 siblings of patients with bilateral retinoblastoma with no intraocular disease.3 In most cases, patients with PNET are seen for symptoms of increased intracranial pressure after the tumor is large, and the disease is usually fatal.3

Patients diagnosed with small, asymptomatic PNETs, however, have improved survival rates when treated with chemotherapy and radiation.4 This has led to routine neuroimaging among patients with heritable retinoblastoma to detect preclinical intracranial neoplasms in many centers. However, no . . . [Full Text of this Article]

Report of Cases

Case 1

Case 2

Case 3


Comment
Corresponding author: Joan M. O'Brien, MD, Box 0730, University of California, San Francisco, San Francisco, CA 94143-0730 (e-mail: aleja@itsa.ucsf.edu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening for Pineoblastoma in Patients With Retinoblastoma
Moll et al.
Arch Ophthalmol 2002;120:1774-1774.
FULL TEXT  

Three-dimensional High-Resolution Magnetic Resonance Imaging of Ocular and Orbital Malignancies
McCaffery et al.
Arch Ophthalmol 2002;120:747-754.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.